Navigation Links
Kroger Recalls Peanut Butter Bakery Cookies and Select Cakes Due to Possible Health Risk
Date:1/31/2009

CINCINNATI, Jan. 31 /PRNewswire-FirstCall/ -- The Kroger Co. (NYSE: KR) said today it is recalling peanut butter store-baked and store-packaged cookies and select cakes sold in its family of stores because the products have the potential to be contaminated with Salmonella.

Stores under the following names in the 31 states where Kroger operates are included in this recall: Kroger, Ralphs, Fred Meyer, Food 4 Less, Fry's, King Soopers, Smith's, Dillons, QFC, City Market, Foods Co., Jay C, Scott's, Owen's, Baker's, Gerbes, Hilander and Pay Less.

No illnesses have been reported in connection with the cookies and cakes.

Item Descriptions:

Kroger is recalling all packages of the following Kroger, Store-Brand and Private Selection store-baked and store-packaged cookies:

  • Peanut Butter Cookies - Regular, Jumbo, Decorated, Iced, Gourmet, Mini and Sandwich cookies
  • Assorted and Variety Bakery Cookies - Regular and Jumbo
  • Private Selection Peanut Chocolate Chunk Cookies
  • Private Selection Gourmet Variety Cookie Trays

Kroger is recalling all sizes of the following Private Selection Cakes, including whole, half and packaged slices:

  • Private Selection Chocolate Trio Single-Layer and Double-Layer Iced Cakes

Customers who have purchased any of the cookies or cakes listed above should not consume these products and should return them to a store for a full refund or replacement.

The products Kroger is recalling may be associated with the peanut product recall by Peanut Corporation of America (PCA). The FDA has indicated that PCA is the focus of its investigation into Salmonella-related illnesses that may be linked to contaminated peanut products. For more information, please visit the FDA's website at www.fda.gov.

Kroger continues to follow FDA guidelines and, for the safety of customers, has withdrawn other products from sale that contain peanut ingredients implicated in this outbreak, as directed by the FDA and suppliers involved.

Salmonella is an organism that can cause serious and sometimes fatal infections, particularly in young children, frail or elderly people, and others with weakened immune systems. Healthy persons infected with Salmonella often experience fever, diarrhea, nausea, vomiting and abdominal pain. For more information on Salmonella, please visit the Centers for Disease Control and Prevention's website at www.cdc.gov.

According to the FDA, peanut butter sold in jars, including Kroger brand peanut butter sold in the retailer's family of stores, is not involved in the ongoing investigation.

Customers who have questions about the cookie and cake recall may contact Kroger toll-free at (800) 632-6900. For more information, please visit Kroger's website at www.kroger.com/recalls.

Kroger is notifying customers about this recall by placing signs in stores in bakery departments. Kroger is also activating its register receipt and phone call notification systems to alert customers about recalls of products they may have purchased.

Kroger, one of the nation's largest retail grocery chains, employs more than 320,000 associates who serve customers in 2,477 supermarkets and multi-department stores in 31 states. Kroger operates stores under two dozen local banner names including Kroger, Ralphs, Fred Meyer, Food 4 Less, Fry's, King Soopers, Smith's, Dillons, QFC and City Market. In addition, Kroger associates serve customers in 778 convenience stores, 392 fine jewelry stores and 750 supermarket fuel centers the Company operates. Kroger also operates 41 food processing plants in the U.S. Headquartered in Cincinnati, Ohio, Kroger focuses its charitable efforts on supporting hunger relief, health and wellness initiatives, and local schools and grassroots organizations in the communities it serves. For more information about the Company, please visit www.kroger.com.


'/>"/>
SOURCE The Kroger Co.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Study Shows Leconotide, an Investigative Calcium Channel Blocker, Has Potential as a Selective, Efficacious, Non-Opioid Pain Treatment
2. Inclinix Releases Next Generation Critical Population Research(R) (CPR) for Clinical Trial Investigator Site Selection and Patient Recruitment
3. Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program
4. Halozyme Therapeutics Announces Roche Begins Phase 1 Clinical Trial and Selects Fourth Exclusive Biologic Target
5. TargeGen Affiliates Scheduled for Oral Presentation of Interim Clinical Trial Data at 2008 ASH Meeting in San Francisco for TG101348, a Potent, Selective, Oral JAK2 Inhibitor in Myeloproliferative Disease Patients
6. Sarah Cannon Research Institute Selects OmniComm Systems Electronic Data Capture Solution, TrialMaster(TM), for Clinical Trials Management
7. SELECT TRIAL Used Selenomethionine Instead of High-Selenium Yeast, SelenoExcell(R) - Previous Research has Shown SelenoExcell(R) Supplementation to Reduce Lung, Colon and Prostate Cancers by as Much as 63%, Says Cypress Systems, Inc.
8. Texas Cardiac Arrhythmia Institute at St. Davids Medical Center Selected to Conduct Clinical Trial for Device to Treat Atrial Fibrillation
9. XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention
10. BRIDION(R) (sugammadex) Injection - First and Only Selective Relaxant Binding Agent - Approved in European Union
11. Cepheid GeneXpert(R) System and Xpert(TM) MRSA Selected for up to 11 Victoria, Australia Hospitals in Rollout of Start Clean Strategy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... April 28, 2016 Oramed Pharmaceuticals Inc. ... pharmaceutical company focused on the development of oral drug delivery ... upcoming PIONEERS 2016 conference, presented by Joseph Gunnar ... New York . Nadav Kidron , ... conference. Presentation Details:   PIONEERS ...
(Date:4/28/2016)... , April 28, 2016 ... Review, H1 2016" is a report that provides ... helps strengthen R&D pipelines by identifying new targets ... Company Profiles discussed in this H1 ... Farmaceutiche Riunite Srl, AbbVie Inc., Abiogen Pharma S.p.A., ...
(Date:4/27/2016)... 27, 2016   ... in Recurring Consumable Sales  Clinical sales grow ... Technologies (Euronext: MKEA, OTCQX: MKEAY) inventor of Cellvizio®, the ... for the first quarter ended March 31, 2016 and ... of its commercial strategy. First Quarter 2016 ...
Breaking Medicine Technology:
(Date:4/29/2016)... ... April 29, 2016 , ... ... team BioCellection won the $30,000 Perlman Grand Prize of the 2016 Wharton Business ... Award, the Michelson People’s Choice Award, and the Committee Award for Most ‘Wow ...
(Date:4/29/2016)... , ... April 29, 2016 , ... ... Canadian Celiac Association (CCA), is pleased to announce the launch of the ... nutritional articles, recipes, and more. The purpose of the GFCP Scoop ...
(Date:4/29/2016)... ... April 29, 2016 , ... New York City based oral and maxillofacial surgeon Dr. ... very effective way to treat obstructive sleep apnea. Dr. Jamali is proud to offer this ... procedure that involves one or both jaw bones. This surgery is performed to correct the ...
(Date:4/29/2016)... ... April 29, 2016 , ... Jvion, the market ... funding led by Eastside Partners, with participation from existing investor Martin Ventures. ... and accelerate its technology and product roadmap. , “Jvion is experiencing ...
(Date:4/29/2016)... ... 2016 , ... CURE Media Group , the nation’s ... today announced that Lynne Malestic, RN, of Eisenhower Lucy Curci Cancer Center in ... Oncology Nursing , which honors nurses who have dedicated their careers to helping ...
Breaking Medicine News(10 mins):